Aspire Biopharma Holdings, Inc. 10-Q

Accession 0001410578-22-001691

Filing information

CIK: 0001847345
Report date: 2022-03-31
Filing date: 2022-05-16
Form: 10-Q
Primary document: pwup-20220331x10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.